U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07623174) titled 'A Study of Fruquintinib in Adults With Metastatic Colorectal Cancer in Poland' on May 29.
Brief Summary: Metastatic colorectal cancer or mCRC is a cancer that starts in the parts of the large intestine (the colon or rectum) and has already spread to other parts of the body. This cancer can be hard to treat because it can behave differently from one person to another. Over time, treatments may stop working, and side effects can build up. In later treatment stages, there are only a few standard medicine options available. Because of this, studies often look at both how long people live and how treatment affects quality of life.
The ma...